Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1952 1
1963 1
1964 1
1965 1
1971 1
1972 1
1975 2
1976 1
1977 3
1978 3
1979 2
1980 2
1981 3
1982 3
1983 2
1984 3
1985 3
1986 6
1987 6
1988 5
1989 6
1990 8
1991 7
1992 6
1993 9
1994 3
1995 6
1996 8
1997 10
1998 10
1999 7
2000 14
2001 18
2002 13
2003 24
2004 27
2005 44
2006 47
2007 35
2008 35
2009 47
2010 55
2011 64
2012 49
2013 43
2014 45
2015 50
2016 65
2017 105
2018 117
2019 151
2020 172
2021 180
2022 165
2023 203
2024 153

Text availability

Article attribute

Article type

Publication date

Search Results

1,854 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Management of Hyperkalemia.
Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR. Palmer BF, et al. Mayo Clin Proc. 2021 Mar;96(3):744-762. doi: 10.1016/j.mayocp.2020.06.014. Epub 2020 Nov 5. Mayo Clin Proc. 2021. PMID: 33160639 Free article. Review.
Recent clinical studies suggest that the newer K(+) binders (patiromer sorbitex calcium and sodium zirconium cyclosilicate) may facilitate optimization of RAASi therapy. Enhancing the knowledge of primary care physicians and internists with respect to the safety pro …
Recent clinical studies suggest that the newer K(+) binders (patiromer sorbitex calcium and sodium zirconium cyclosilicate) ma …
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.
Ferreira JP, Butler J, Rossignol P, Pitt B, Anker SD, Kosiborod M, Lund LH, Bakris GL, Weir MR, Zannad F. Ferreira JP, et al. J Am Coll Cardiol. 2020 Jun 9;75(22):2836-2850. doi: 10.1016/j.jacc.2020.04.021. J Am Coll Cardiol. 2020. PMID: 32498812 Free article. Review.
Potassium (K(+)) is the most abundant cation in humans and is essential for normal cellular function. ...Hypokalemia is associated with excess morbidity and mortality in heart failure. The lower the K(+) levels, the higher the risk, starting at K(+) levels be …
Potassium (K(+)) is the most abundant cation in humans and is essential for normal cellular function. ...Hypokalemia is associated wi …
New information on phosphate binder interactions with vitamin K.
Bover J, Navarro-González JF, daSilva I. Bover J, et al. Nefrologia (Engl Ed). 2020 May-Jun;40(3):369-370. doi: 10.1016/j.nefro.2019.10.001. Epub 2019 Dec 24. Nefrologia (Engl Ed). 2020. PMID: 31882158 Free article. English, Spanish. No abstract available.
A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia.
Cañas AE, Troutt HR, Jiang L, Tonthat S, Darwish O, Ferrey A, Lotfipour S, Kalantar-Zadeh K, Hanna R, Lau WL. Cañas AE, et al. BMC Nephrol. 2023 Apr 5;24(1):89. doi: 10.1186/s12882-023-03145-x. BMC Nephrol. 2023. PMID: 37016309 Free PMC article. Clinical Trial.
BACKGROUND: The KBindER (K(+) Binders in Emergency Room and hospitalized patients) clinical trial is the first head-to-head evaluation of oral potassium binders (cation-exchange resins) for acute hyperkalemia therapy. ...DISCUSSION: The findings from our stud …
BACKGROUND: The KBindER (K(+) Binders in Emergency Room and hospitalized patients) clinical trial is the first head-to-head ev …
Hyperkalemia in CKD: an overview of available therapeutic strategies.
Costa D, Patella G, Provenzano M, Ielapi N, Faga T, Zicarelli M, Arturi F, Coppolino G, Bolignano D, De Sarro G, Bracale UM, De Nicola L, Chiodini P, Serra R, Andreucci M. Costa D, et al. Front Med (Lausanne). 2023 Jul 31;10:1178140. doi: 10.3389/fmed.2023.1178140. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37583425 Free PMC article. Review.
Furthermore, by describing the prognostic impact on mortality and on the progression of renal damage, we want to outline the strategies currently available for the control of potassium (K+) plasma levels....
Furthermore, by describing the prognostic impact on mortality and on the progression of renal damage, we want to outline the strategies curr …
[Hyperphosphatemia in dialysis: which binder?].
Alfieri C, Malberti F, Mazzaferro S, Gallieni M, Russo D, Messa P, Cozzolino M. Alfieri C, et al. G Ital Nefrol. 2018 Sep;35(5):2018-vol5. G Ital Nefrol. 2018. PMID: 30234231 Free article. Review. Italian.
This goal should be achieved by combining dietary counseling, optimizing dialysis procedures and prescribing phosphate binders. Despite the availability of several binders, the "ideal" phosphate binder that combines high efficacy, low pills burden, minimal si …
This goal should be achieved by combining dietary counseling, optimizing dialysis procedures and prescribing phosphate binders. Despi …
Ultrastable Graphite-Potassium Anode through Binder Chemistry.
Mao Z, Shi X, Zhang T, Zheng Z, Liang X, Wang R, Jin J, He B, Gong Y, Wang H. Mao Z, et al. Small. 2023 Dec;19(50):e2302987. doi: 10.1002/smll.202302987. Epub 2023 Aug 30. Small. 2023. PMID: 37649227
Unfortunately, it suffers from fast capacity decay during K(+) storage. Herein, an ultrastable graphite-potassium anode is developed through binder chemistry. Polyvinyl alcohol (PVA) is utilized as a water-soluble binder to generate a uniform and robust KF-ri …
Unfortunately, it suffers from fast capacity decay during K(+) storage. Herein, an ultrastable graphite-potassium anode is developed …
Pharmacodynamic effects of the K(+) binder patiromer in a novel chronic hyperkalemia model in spontaneously hypertensive rats.
Iyer SPN, Lee L, Li L. Iyer SPN, et al. Physiol Rep. 2020 Sep;8(18):e14572. doi: 10.14814/phy2.14572. Physiol Rep. 2020. PMID: 32965782 Free PMC article.
Using the spontaneously hypertensive rat (SHR) model as a more relevant disease template, as well as surgical (unilateral nephrectomy), dietary (3% potassium [K(+) ] supplementation), and pharmacological (amiloride) interventions, we were able to stably induce HK on a chro …
Using the spontaneously hypertensive rat (SHR) model as a more relevant disease template, as well as surgical (unilateral nephrectomy), diet …
Phosphate binder therapy for attainment of K/DOQI bone metabolism guidelines.
Nolan CR. Nolan CR. Kidney Int Suppl. 2005 Jul;(96):S7-14. doi: 10.1111/j.1523-1755.2005.00449.x. Kidney Int Suppl. 2005. PMID: 15954948 Free article. Review.
Although calcium-based phosphate binders (CBPB) are cost effective, there are long-term safety concerns pertaining to their postulated role in the progression of cardiovascular calcification. ...As calcium acetate is more efficacious and cost effective than sevelamer hydro …
Although calcium-based phosphate binders (CBPB) are cost effective, there are long-term safety concerns pertaining to their postulate …
Carboxymethyl Cellulose Binder Greatly Stabilizes Porous Hollow Carbon Submicrospheres in Capacitive K-Ion Storage.
Li J, Zhuang N, Xie J, Zhu Y, Lai H, Qin W, Javed MS, Xie W, Mai W. Li J, et al. ACS Appl Mater Interfaces. 2019 May 1;11(17):15581-15590. doi: 10.1021/acsami.9b02060. Epub 2019 Apr 19. ACS Appl Mater Interfaces. 2019. PMID: 30969099
On account of the large radius of K-ions, the electrodes can suffer huge deformation during K-ion insertion and extraction processes. ...Furthermore, based on the rational design, our hollow carbon submicrospheres also exhibit 62.3% specific capacity contribution be …
On account of the large radius of K-ions, the electrodes can suffer huge deformation during K-ion insertion and extraction pro …
1,854 results